{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:08:15Z","timestamp":1788786495814,"version":"build-2803163510"},"reference-count":106,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hainan Provincial Key Research and Development Program","award":["ZDYF2025SHFZ044"],"award-info":[{"award-number":["ZDYF2025SHFZ044"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360838"],"award-info":[{"award-number":["82360838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82360838"],"award-info":[{"award-number":["82360838"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Academic Enhancement Support Program of Hainan Medical University","award":["2025183"],"award-info":[{"award-number":["2025183"]}]},{"award":["2025183"],"award-info":[{"award-number":["2025183"]}],"id":[{"id":"https:\/\/ror.org\/004eeze55","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Undergraduate Research and Innovation Training Program of Hainan Medical University","award":["RZ2600001114"],"award-info":[{"award-number":["RZ2600001114"]}]},{"award":["RZ2600001114"],"award-info":[{"award-number":["RZ2600001114"]}],"id":[{"id":"https:\/\/ror.org\/004eeze55","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Glioblastoma (GBM) is the most aggressive primary brain malignancy in adults, which remains difficult to treat because of extensive intratumoral heterogeneity, intrinsic and acquired treatment resistance, a profoundly immunosuppressive tumor microenvironment (TME), and restricted drug delivery across the blood\u2013brain barrier (BBB). Owing to their relatively low molecular mass, potential for BBB penetration, and ability to modulate multiple targets, natural and synthetic compounds have attracted increasing interest as candidates for GBM treatment. This narrative review summarizes the mechanisms by which naturally derived compounds\u2014including saponins, flavonoids, and sesquiterpene lactones\u2014and synthetic small molecules exert anti-GBM effects on tumor and the TME. Their reported actions include suppressing key prosurvival pathways, such as the phosphoinositide 3-kinase\/protein kinase B\/mechanistic target of rapamycin (PI3K\/AKT\/mTOR), nuclear factor kappa B (NF-\u03baB), and mutant p53 signaling; activating regulated cell-death processes, including apoptosis, pyroptosis, and parthanatos, as well as autophagy-associated cell death; and remodeling the tumor immune milieu to promote CD8+ T-cell infiltration. In preclinical models, some of these agents also overcome temozolomide (TMZ) resistance and resensitize glioma stem cells (GSCs) to chemotherapy or radiotherapy. Future studies should prioritize molecularly informed patient stratification, rational combination strategies, and advanced nanocarrier-mediated delivery platforms to facilitate the clinical translation of small-molecule therapeutics for GBM.<\/jats:p>","DOI":"10.3390\/ijms27177798","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:36Z","timestamp":1788256116000},"page":"7798","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natural and Synthetic Compounds, Swords for Glioblastoma Therapy: From Tumor to Its Microenvironment"],"prefix":"10.3390","volume":"27","author":[{"given":"Bingxia","family":"Huang","sequence":"first","affiliation":[{"name":"Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, Hainan Key Laboratory for Research and Development of Tropical Herbs, Haikou Key Laboratory of Li Nationality Medicine, School of Pharmacy, Hainan Medical University, Haikou 571199, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8021-0726","authenticated-orcid":false,"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, Hainan Key Laboratory for Research and Development of Tropical Herbs, Haikou Key Laboratory of Li Nationality Medicine, School of Pharmacy, Hainan Medical University, Haikou 571199, China"},{"name":"Hainan Academy of Medical Sciences, Hainan Medical University, Haikou 571199, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"102811","DOI":"10.1016\/j.canep.2025.102811","article-title":"Adult glioblastoma in England: Incidence, treatment, and outcomes with novel population-based strata","volume":"97","author":"Mauricaite","year":"2025","journal-title":"Cancer Epidemiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Xu, Z., Liu, Y., Ye, M., Chen, R., Cao, Z., Zhou, H., and Zhou, Y. (2025). Analysis of epidemiology and nomogram construction for prediction and clinical decision-making in gliomas. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1624142"},{"key":"ref_3","first-page":"e8195","article-title":"Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population","volume":"12","author":"Grech","year":"2020","journal-title":"Cureus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/neuonc\/now038","article-title":"Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: A report of the Children\u2019s Oncology Group ACNS0423 study","volume":"18","author":"Jakacki","year":"2016","journal-title":"Neuro-Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/neuonc\/noab003","article-title":"PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma","volume":"23","author":"Wu","year":"2021","journal-title":"Neuro-Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/2772432817666220517163609","article-title":"Efficacy of Anti-VEGF Drugs Based Combination Therapies in Recurrent Glioblastoma: Systematic Review and Meta-Analysis","volume":"19","author":"Solipuram","year":"2024","journal-title":"Curr. Rev. Clin. Exp. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/neuonc\/nop027","article-title":"Tumor invasion after treatment of glioblastoma with bevacizumab: Radiographic and pathologic correlation in humans and mice","volume":"12","author":"Fuller","year":"2010","journal-title":"Neuro-Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"vdac041","DOI":"10.1093\/noajnl\/vdac041","article-title":"Phase I\/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)","volume":"4","author":"Galanis","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.3346\/jkms.2024.39.e244","article-title":"Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients with Recurrent Glioblastoma: A Nationwide Population-Based Study","volume":"39","author":"Lee","year":"2024","journal-title":"J. Korean Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Alcaniz, J., Winkler, L., Dahlmann, M., Becker, M., Orthmann, A., Haybaeck, J., Krassnig, S., Skofler, C., Kratzsch, T., and Kuhn, S.A. (2023). Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1129627"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/pr.117.014944","article-title":"Current Challenges and Opportunities in Treating Glioblastoma","volume":"70","author":"Shergalis","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12031-026-02536-7","article-title":"Integrating Molecular Pathology, Tumor Microenvironment, and Novel Therapies to Overcome Resistance in Glioblastoma","volume":"76","author":"Kumari","year":"2026","journal-title":"J. Mol. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Barzegar Behrooz, A., Talaie, Z., Jusheghani, F., \u0141os, M.J., Klonisch, T., and Ghavami, S. (2022). Wnt and PI3K\/Akt\/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031353"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jor.2023.08.007","article-title":"Robotics and navigation in spine surgery: A narrative review","volume":"44","author":"Zawar","year":"2023","journal-title":"J. Orthop."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/07357907.2025.2563204","article-title":"Advanced Machine Learning and Multiomics Reveal Tumor Dynamics and Therapeutic Opportunities in Glioblastoma Multiforme","volume":"44","author":"Li","year":"2026","journal-title":"Cancer Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"vdae229","DOI":"10.1093\/noajnl\/vdae229","article-title":"Transcriptomic analysis of EGFR co-expression and activation in glioblastoma reveals associations with its ligands","volume":"7","author":"Ghisai","year":"2025","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhu, F., Qiu, J., Ye, H., Su, W., Wang, R., and Fu, Y. (2025). The Prognostic Significance of Epidermal Growth Factor Receptor Amplification and Epidermal Growth Factor Receptor Variant III Mutation in Glioblastoma: A Systematic Review and Meta-Analysis with Implications for Targeted Therapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26083539"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"ra4","DOI":"10.1126\/scisignal.2000014","article-title":"EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma","volume":"2","author":"Fan","year":"2009","journal-title":"Sci. Signal."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"118237","DOI":"10.1016\/j.biopha.2025.118237","article-title":"The mTOR pathway in Gliomas: From molecular insights to targeted therapies","volume":"189","author":"Pournajaf","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41419-022-05449-6","article-title":"Mutual regulation between phosphofructokinase 1 platelet isoform and VEGF promotes glioblastoma tumor growth","volume":"13","author":"Lim","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00210-024-03564-z","article-title":"Unraveling the mechanisms of glioblastoma\u2019s resistance: Investigating the influence of tumor suppressor p53 and non-coding RNAs","volume":"398","author":"Alshammari","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"188556","DOI":"10.1016\/j.bbcan.2021.188556","article-title":"Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting","volume":"1876","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"eadj5962","DOI":"10.1126\/scitranslmed.adj5962","article-title":"Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization","volume":"16","author":"Chen","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107620","DOI":"10.1016\/j.bioorg.2024.107620","article-title":"Targeting MDM2-p53 interaction in Glioblastoma: Transcriptomic analysis and Peptide-Based inhibition strategy","volume":"150","author":"Han","year":"2024","journal-title":"Bioorg. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41418-020-00606-w","article-title":"TRIM22 activates NF-\u03baB signaling in glioblastoma by accelerating the degradation of I\u03baB\u03b1","volume":"28","author":"Ji","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1038\/s41598-025-92969-8","article-title":"Periostin-mediated activation of NF-\u03baB signaling promotes tumor progression and chemoresistance in glioblastoma","volume":"15","author":"Shang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e71078","DOI":"10.1096\/fj.202500095R","article-title":"STC1-Based Activation of NF-\u03baB Signaling Pathway Induces Epthithelial\u2013Mesenchymal Transition Thus Promotes Progression and Temozolomide Resistance of Glioblastoma","volume":"39","author":"Wang","year":"2025","journal-title":"FASEB J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zappe, K., Jenik, A., Berger, D., Uhlik, L., Heffeter, P., and Cichna-Markl, M. (2025). DNA Methylation and Transcript Variant Analysis of CDKN2A Exon 2 Despite High Sequence Identity with CDKN2B Exon 2. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136128"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"148957","DOI":"10.1016\/j.ijbiomac.2025.148957","article-title":"The dual role of cyclin D1: Unraveling its tumor-promoting mechanisms and opportunities for therapeutics","volume":"333","author":"Taheri","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10014-023-00473-6","article-title":"FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma","volume":"41","author":"Boyle","year":"2024","journal-title":"Brain Tumor Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lan, Z., Li, X., and Zhang, X. (2024). Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25053040"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Asma, S.T., Acaroz, U., Imre, K., Morar, A., Shah, S.R.A., Hussain, S.Z., Arslan-Acaroz, D., Demirbas, H., Hajrulai-Musliu, Z., and Istanbullugil, F.R. (2022). Natural Products\/Bioactive Compounds as a Source of Anticancer Drugs. Cancers, 14.","DOI":"10.3390\/cancers14246203"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2020.12.036","article-title":"Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy","volume":"330","author":"Zhu","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Navone, S.E., Guarnaccia, L., Rizzaro, M.D., Begani, L., Barilla, E., Alotta, G., Garzia, E., Caroli, M., Ampollini, A., and Violetti, A. (2024). Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010130"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3171\/2016.1.JNS152077","article-title":"Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration","volume":"126","author":"Clark","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.scr.2013.04.004","article-title":"Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells","volume":"11","author":"Sato","year":"2013","journal-title":"Stem Cell Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12263-007-0056-z","article-title":"The interactions of flavonoids within neuronal signalling pathways","volume":"2","author":"Spencer","year":"2007","journal-title":"Genes Nutr."},{"key":"ref_40","first-page":"1084","article-title":"Anticancer effects of catechin flavonoid in human glioma cells are mediated via autophagy induction, cell cycle arrest, inhibition of cell migration and invasion and targeting MAPK\/ERK signalling pathway","volume":"25","author":"Zhu","year":"2020","journal-title":"J. BUON"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"118158","DOI":"10.1016\/j.lfs.2020.118158","article-title":"Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT\/ERK1\/2\/STAT3-SOX2\/Snail signaling pathway","volume":"378","author":"Chen","year":"2020","journal-title":"Life Sci."},{"key":"ref_42","first-page":"2508","article-title":"Icariside II induces cell cycle arrest and apoptosis in human glioblastoma cells through suppressing Akt activation and potentiating FOXO3a activity","volume":"9","author":"Quan","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/19768354.2016.1229216","article-title":"Baicalein induces the apoptosis of U251 glioblastoma cell lines via the NF-kB-p65-mediated mechanism","volume":"20","author":"Jiang","year":"2016","journal-title":"Anim. Cells Syst."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.3892\/mmr.2016.5460","article-title":"Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-\u03baB\/MMP-9","volume":"14","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbi.2019.05.003","article-title":"The flavonoid rutin and its aglycone quercetin modulate the microglia inflammatory profile improving antiglioma activity","volume":"85","author":"Oliveira","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"154933","DOI":"10.1016\/j.phymed.2023.154933","article-title":"Quercetin induces MGMT+ glioblastoma cells apoptosis via dual inhibition of Wnt3a\/\u03b2-Catenin and Akt\/NF-\u03baB signaling pathways","volume":"118","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejps.2016.01.019","article-title":"Quercetin derivative induces cell death in glioma cells by modulating NF-\u03baB nuclear translocation and caspase-3 activation","volume":"84","author":"Kiekow","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7150\/thno.49250","article-title":"Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1\/PI3K\/AKT signaling","volume":"11","author":"Hou","year":"2021","journal-title":"Theranostics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2018.04.033","article-title":"Inhibition of NF-\u03baB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression","volume":"428","author":"Yu","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Nakabayashi, H., and Shimizu, K. (2012). Involvement of Akt\/NF-\u03baB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-453"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13046-017-0563-8","article-title":"Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKK\u03b2 kinase activity and interrupting NF-\u03baB\/COX-2-mediated signaling cascades","volume":"36","author":"Wang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"216927","DOI":"10.1016\/j.canlet.2024.216927","article-title":"Small-molecule Molephantin induces apoptosis and mitophagy flux blockage through ROS production in glioblastoma","volume":"592","author":"Ling","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"110514","DOI":"10.1016\/j.neuropharm.2025.110514","article-title":"Forsythoside B suppresses glioblastoma by upregulating the expression of PTPRN","volume":"277","author":"Chen","year":"2025","journal-title":"Neuropharmacology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1007\/s11033-020-05500-9","article-title":"Berberine induces apoptosis in glioblastoma multiforme U87MG cells via oxidative stress and independent of AMPK activity","volume":"47","author":"Palma","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1089\/can.2021.0098","article-title":"Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment","volume":"8","author":"Khodadadi","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Lah, T.T., Novak, M., Pena Almidon, M.A., Marinelli, O., \u017dvar Ba\u0161kovi\u010d, B., Majc, B., Mlinar, M., Bo\u0161njak, R., Breznik, B., and Zomer, R. (2021). Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma. Cells, 10.","DOI":"10.3390\/cells10020340"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"147515","DOI":"10.1016\/j.brainres.2021.147515","article-title":"Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation)","volume":"1766","author":"Zhou","year":"2021","journal-title":"Brain Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s11064-018-2478-y","article-title":"Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor \u03b2-Induced Epithelial\u2013Mesenchymal Transition","volume":"43","author":"Wang","year":"2018","journal-title":"Neurochem. Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Dell\u2019Albani, P., Carbone, C., Sposito, G., Spatuzza, M., Chiacchio, M.A., Grasso, R., Legnani, L., Santonocito, D., Puglia, C., and Parenti, R. (2024). Effect of Ferulic Acid Loaded in Nanoparticle on Tissue Transglutaminase Expression Levels in Human Glioblastoma Cell Line. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158397"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3171\/2016.8.JNS161197","article-title":"Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell\u2013like spheroids, and tumor xenografts through multiple cell signaling pathways","volume":"127","author":"Wang","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"217429","DOI":"10.1016\/j.canlet.2024.217429","article-title":"Sulforaphane potentiates the efficacy of chemoradiotherapy in glioblastoma by selectively targeting thioredoxin reductase 1","volume":"611","author":"Ge","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_62","first-page":"9264","article-title":"Bufotalin enhances apoptosis and TMZ chemosensitivity of glioblastoma cells by promoting mitochondrial dysfunction via AKT signaling pathway","volume":"16","author":"Zhu","year":"2024","journal-title":"Aging"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/cns.12163","article-title":"Curcumin Suppresses Malignant Glioma Cells Growth and Induces Apoptosis by Inhibition of SHH\/GLI1 Signaling Pathway in Vitro and Vivo","volume":"19","author":"Du","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2014.12.044","article-title":"Autophagy inhibition improves the efficacy of curcumin\/temozolomide combination therapy in glioblastomas","volume":"358","author":"Braganhol","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","article-title":"Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells","volume":"49","author":"Zhu","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2174\/1871527317666180611090006","article-title":"A Multi-targeted Natural Flavonoid Myricetin Suppresses Lamellipodia and Focal Adhesions Formation and Impedes Glioblastoma Cell Invasiveness and Abnormal Motility","volume":"17","author":"Zhao","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2001-1326-1-24","article-title":"Versatile inhibitory effects of the flavonoid-derived PI3K\/Akt inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells","volume":"1","author":"Imai","year":"2012","journal-title":"Clin. Transl. Med."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Markov, A.V., Moralev, A.D., and Odarenko, K.V. (2025). Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural\u2013Mesenchymal Transition. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010133"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ramar, V., Guo, S., Wang, G., and Liu, M. (2025). The Pivotal Role of NF-\u03baB in Glioblastoma: Mechanisms of Activation and Therapeutic Implications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26167883"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Zhu, X., Pan, S., Li, R., Chen, Z., Xie, X., Han, D., Lv, S., and Huang, Y. (2021). Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.667884"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e1601","DOI":"10.1038\/cddis.2014.566","article-title":"Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma","volume":"6","author":"Singer","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"110995","DOI":"10.1016\/j.cbi.2024.110995","article-title":"Cannabidiol induces ERK activation and ROS production to promote autophagy and ferroptosis in glioblastoma cells","volume":"394","author":"Kim","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41417-020-0163-1","article-title":"Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6\/AXL\/SRC signaling","volume":"27","author":"Dong","year":"2020","journal-title":"Cancer Gene Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41420-023-01632-6","article-title":"Osimertinib induces paraptosis and TRIP13 confers resistance in glioblastoma cells","volume":"9","author":"Hu","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Furqan, M., Elliott, R.J.R., Nagle, P.W.K., Dawson, J.C., Masalmeh, R., Garcia, V.A., Munro, A.F., Drake, C., Morrison, G.M., and Pollard, S.M. (2025). Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17050549"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00280-021-04242-0","article-title":"Foretinib induces G2\/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition","volume":"87","author":"Gortany","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1111\/cas.15141","article-title":"Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance","volume":"112","author":"Yamamuro","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"eadn6274","DOI":"10.1126\/scitranslmed.adn6274","article-title":"A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma","volume":"17","author":"Rendo","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41401-020-0404-8","article-title":"Avasimibe exerts anticancer effects on human glioblastoma cells via inducing cell apoptosis and cell cycle arrest","volume":"42","author":"Liu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41401-021-00752-y","article-title":"Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle","volume":"43","author":"Ren","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"176274","DOI":"10.1016\/j.ejphar.2023.176274","article-title":"Metformin-induced reduction of CCR8 enhances the anti-tumor immune response of PD-1 immunotherapy in glioblastoma","volume":"964","author":"Li","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"113691","DOI":"10.1016\/j.yexcr.2023.113691","article-title":"Lower dose of metformin combined with artesunate induced autophagy-dependent apoptosis of glioblastoma by activating ROS-AMPK-mTOR axis","volume":"430","author":"Ding","year":"2023","journal-title":"Exp. Cell Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.1021\/acs.jmedchem.4c00128","article-title":"Discovery of Novel Small-Molecule-Based Potential PD-L1\/EGFR Dual Inhibitors with High Druggability for Glioblastoma Immunotherapy","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13046-019-1371-0","article-title":"Modulating lncRNA SNHG15\/CDK6\/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Pawlak, W., and Majchrzak-Celi\u0144ska, A. (2025). Tinostamustine (EDO-S101) and Its Combination with Celecoxib or Temozolomide as a Therapeutic Option for Adult-Type Diffuse Gliomas. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020661"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"153429","DOI":"10.1016\/j.prp.2021.153429","article-title":"DNA methylation and protein expression of Wnt pathway markers in progressive glioblastoma","volume":"222","author":"Tompa","year":"2021","journal-title":"Pathol.-Res. Pract."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"101233","DOI":"10.1016\/j.neo.2025.101233","article-title":"Generation of orthotopic intracranial glioblastoma patient-derived xenograft models: Insights into extrachromosomal DNA-driven MYC(N) and PDGFRA oncogene amplification and preliminary therapeutic evaluation","volume":"69","author":"Tran","year":"2025","journal-title":"Neoplasia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"113931","DOI":"10.1016\/j.jconrel.2025.113931","article-title":"Multimodal nanoparticles co-delivering bevacizumab and dichloroacetate for dual targeting of neoangiogenesis and hyperglycolysis in glioblastoma treatment","volume":"384","author":"Pacheco","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Cirotti, C., Contadini, C., and Baril\u00e0, D. (2020). SRC Kinase in Glioblastoma: News from an Old Acquaintance. Cancers, 12.","DOI":"10.3390\/cancers12061558"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s43856-025-01279-7","article-title":"Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme","volume":"6","author":"Angom","year":"2026","journal-title":"Commun. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(18)31791-4","article-title":"Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG\/NOA\u201309): A randomised, open-label, phase 3 trial","volume":"393","author":"Herrlinger","year":"2019","journal-title":"Lancet"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13045-018-0576-6","article-title":"The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma","volume":"11","author":"Festuccia","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2018.07.034","article-title":"S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tumor growth","volume":"439","author":"Gao","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41591-019-0349-y","article-title":"Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma","volume":"25","author":"Zhao","year":"2019","journal-title":"Nat. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Han, J.M., and Jung, H.J. (2022). Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells. Molecules, 27.","DOI":"10.3390\/molecules27227968"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/1534735418762537","article-title":"Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats","volume":"17","author":"Wang","year":"2018","journal-title":"Integr. Cancer Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-018-0805-4","article-title":"3-O-acetyl-11-keto-\u03b2-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2\/M phase","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Tran, T.-A.-T., Kim, Y.-H., Duong, T.-H.-O., Thangaraj, J., Chu, T.-H., Jung, S., Kim, I.-Y., Moon, K.-S., Kim, Y.-J., and Lee, T.-K. (2023). Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1009484"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/1874467214666210420115431","article-title":"Wnt\/\u03b2-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme","volume":"15","author":"Precilla","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_100","first-page":"e69663","article-title":"Regulation of the AKT\/Wnt\/\u03b2-catenin Pathway and Induction of Cuproptosis by Curcumin in Glioblastoma","volume":"227","author":"Yang","year":"2026","journal-title":"J. Vis. Exp."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ijo.2025.5789","article-title":"Nanoparticle-based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review)","volume":"67","author":"Si","year":"2025","journal-title":"Int. J. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/17435889.2025.2503694","article-title":"Recent advances in nanomaterial-based brain-targeted delivery systems for glioblastoma therapy","volume":"20","author":"Qu","year":"2025","journal-title":"Nanomedicine"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.2147\/DDDT.S530999","article-title":"Harnessing Organoid Platforms for Nanoparticle Drug Development","volume":"19","author":"Chen","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"103072","DOI":"10.1016\/j.ctrv.2025.103072","article-title":"Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: An overview on current approaches and unresolved challenges","volume":"143","author":"Mair","year":"2026","journal-title":"Cancer Treat. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Oudin, A., Moreno-Sanchez, P.M., Baus, V., Niclou, S.P., and Golebiewska, A. (2024). Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence. BMC Cancer, 24.","DOI":"10.1186\/s12885-023-11774-6"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"138106","DOI":"10.1016\/j.foodchem.2023.138106","article-title":"Machine learning prediction for constructing a universal multidimensional information library of Panax saponins (ginsenosides)","volume":"439","author":"Wang","year":"2024","journal-title":"Food Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7798\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:13:45Z","timestamp":1788783225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":106,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177798"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177798","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}